Structure Therapeutics (GPCR) News Today → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free GPCR Stock Alerts $35.88 -0.19 (-0.53%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 5:03 AM | marketbeat.comVictory Capital Management Inc. Cuts Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR)Victory Capital Management Inc. trimmed its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 16.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 125,447 shares of the company's stMay 14 at 6:35 AM | americanbankingnews.comJMP Securities Reaffirms "Market Outperform" Rating for Structure Therapeutics (NASDAQ:GPCR)May 12, 2024 | americanbankingnews.comStructure Therapeutics (NASDAQ:GPCR) Shares Gap Down to $38.65May 10, 2024 | marketbeat.comStructure Therapeutics' (GPCR) "Market Outperform" Rating Reiterated at JMP SecuritiesJMP Securities restated a "market outperform" rating and set a $91.00 price target on shares of Structure Therapeutics in a report on Friday.May 10, 2024 | markets.businessinsider.comBuy Rating for Structure Therapeutics: Promising Pipeline and Financial Stability Ahead of Key Clinical Data ReleaseMay 10, 2024 | investorplace.comGPCR Stock Earnings: Structure Therapeutics Beats EPS for Q1 2024May 9, 2024 | finance.yahoo.comStructure Therapeutics Reports First Quarter 2024 Financial Results and Recent HighlightsMay 9, 2024 | marketbeat.comE Fund Management Co. Ltd. Acquires Shares of 28,589 Structure Therapeutics Inc. (NASDAQ:GPCR)E Fund Management Co. Ltd. bought a new position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 28,589 shares of the company's sMay 7, 2024 | cnbc.comAmgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominanceMay 7, 2024 | americanbankingnews.comStructure Therapeutics' (GPCR) "Overweight" Rating Reiterated at Cantor FitzgeraldMay 3, 2024 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Given Overweight Rating at Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating and set a $65.00 price target on shares of Structure Therapeutics in a research report on Friday.April 30, 2024 | markets.businessinsider.comHere's what to expect from Corcept Therapeutics's earningsApril 30, 2024 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Short Interest Up 9.9% in AprilStructure Therapeutics Inc. (NASDAQ:GPCR - Get Free Report) was the target of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 4,110,000 shares, an increase of 9.9% from the March 31st total of 3,740,000 shares. Currently, 9.9% of the shares of the company are sold short. Based on an average trading volume of 553,100 shares, the short-interest ratio is presently 7.4 days.April 25, 2024 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Trading Up 8%Structure Therapeutics (NASDAQ:GPCR) Shares Up 8%April 24, 2024 | investorplace.com3 Speculative Weight Loss Drug Stocks to Bet On for Big GainsApril 22, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Acquires Shares of 48,085 Structure Therapeutics Inc. (NASDAQ:GPCR)Allspring Global Investments Holdings LLC bought a new position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 48,085 shares of theApril 19, 2024 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Shares Purchased by Federated Hermes Inc.Federated Hermes Inc. increased its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 104.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,267,206 shares of the company's sApril 18, 2024 | msn.comBig pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.April 18, 2024 | marketbeat.comStructure Therapeutics' (GPCR) "Overweight" Rating Reaffirmed at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating and issued a $65.00 target price on shares of Structure Therapeutics in a research report on Thursday.April 18, 2024 | theglobeandmail.comAnalysts Expect This 'Strong Buy' Weight-Loss Stock to DoubleApril 16, 2024 | finance.yahoo.comStructure Therapeutics Inc. (GPCR)April 14, 2024 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Short Interest UpdateStructure Therapeutics Inc. (NASDAQ:GPCR - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 3,740,000 shares, an increase of 15.4% from the March 15th total of 3,240,000 shares. Based on an average daily trading volume, of 584,800 shares, the short-interest ratio is currently 6.4 days. Approximately 9.0% of the shares of the stock are short sold.April 12, 2024 | marketbeat.comCantor Fitzgerald Comments on Structure Therapeutics Inc.'s FY2024 Earnings (NASDAQ:GPCR)Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2024 earnings estimates for Structure Therapeutics in a report released on Tuesday, April 9th. Cantor Fitzgerald analyst P. Agrawal forecasts that the company will earn ($1.10) per sharApril 11, 2024 | markets.businessinsider.comBuy Rating Affirmed for Structure Therapeutics on Upcoming GSBR-1290 Phase 2a Data OptimismApril 10, 2024 | markets.businessinsider.comBuy Rating for Structure Therapeutics on Strong Obesity Drug Prospects and Strategic PartnershipsApril 9, 2024 | msn.comCantor starts Structure at overweight, sees positive data for GLP-1 drugApril 9, 2024 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Stock Price Down 5.5%Structure Therapeutics (NASDAQ:GPCR) Stock Price Down 5.5%April 9, 2024 | marketbeat.comCantor Fitzgerald Initiates Coverage on Structure Therapeutics (NASDAQ:GPCR)Cantor Fitzgerald assumed coverage on Structure Therapeutics in a research report on Tuesday. They set an "overweight" rating and a $65.00 price objective for the company.April 9, 2024 | marketbeat.comStructure Therapeutics Inc. (NASDAQ:GPCR) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Structure Therapeutics Inc. (NASDAQ:GPCR - Get Free Report) have received a consensus rating of "Buy" from the six ratings firms that are presently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy rating. The average 12 month price targetApril 3, 2024 | marketbeat.comLifesci Capital Weighs in on Structure Therapeutics Inc.'s Q1 2024 Earnings (NASDAQ:GPCR)Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) - Analysts at Lifesci Capital issued their Q1 2024 earnings per share estimates for shares of Structure Therapeutics in a research report issued on Monday, April 1st. Lifesci Capital analyst M. Belghiti anticipates that the company will postMarch 30, 2024 | investorplace.com7 Small-Cap Stocks that Wall Street Loves for Good ReasonMarch 27, 2024 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Stock Price Down 3.4%Structure Therapeutics (NASDAQ:GPCR) Trading Down 3.4%March 21, 2024 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Shares Gap Up to $38.63Structure Therapeutics (NASDAQ:GPCR) Shares Gap Up to $38.63March 21, 2024 | marketbeat.comFY2024 EPS Estimates for Structure Therapeutics Inc. Decreased by Leerink Partnrs (NASDAQ:GPCR)Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) - Analysts at Leerink Partnrs reduced their FY2024 earnings per share (EPS) estimates for Structure Therapeutics in a report released on Monday, March 18th. Leerink Partnrs analyst D. Risinger now forecasts that the company will earn ($0.85)March 20, 2024 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Trading Up 5%Structure Therapeutics (NASDAQ:GPCR) Trading Up 5%March 20, 2024 | marketbeat.comQ1 2024 Earnings Forecast for Structure Therapeutics Inc. (NASDAQ:GPCR) Issued By Leerink PartnrsStructure Therapeutics Inc. (NASDAQ:GPCR - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2024 earnings estimates for Structure Therapeutics in a report issued on Monday, March 18th. Leerink Partnrs analyst D. Risinger forecasts that the company will post earnings per sharMarch 20, 2024 | finance.yahoo.comGPCR Dec 2024 50.000 callMarch 20, 2024 | marketbeat.comWellington Management Group LLP Purchases 657,310 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)Wellington Management Group LLP lifted its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR - Free Report) by 312.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 867,579 shares of the company's stock after acquiring an additional 657,310 shaMarch 17, 2024 | finance.yahoo.comGPCR Sep 2024 30.000 putMarch 16, 2024 | finance.yahoo.comGPCR May 2024 30.000 putMarch 16, 2024 | finance.yahoo.comGPCR Apr 2024 30.000 putMarch 15, 2024 | msn.comGPCR Stock Earnings: Structure Therapeutics Beats EPS for Q4 2023March 14, 2024 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Trading Up 2.4%Structure Therapeutics (NASDAQ:GPCR) Shares Up 2.4%March 13, 2024 | bizjournals.comFormer CFO sues Peninsula drug company, alleges domestic violence incident led to her firingMarch 10, 2024 | finance.yahoo.comWe Think Structure Therapeutics (NASDAQ:GPCR) Can Afford To Drive Business GrowthMarch 9, 2024 | finance.yahoo.comGPCR Mar 2024 40.000 putMarch 8, 2024 | globenewswire.comStructure Therapeutics to Present at Leerink Partners Global Biopharma ConferenceMarch 8, 2024 | marketbeat.comStructure Therapeutics (NASDAQ:GPCR) Shares Up 8.3%Structure Therapeutics (NASDAQ:GPCR) Stock Price Up 8.3%March 8, 2024 | globenewswire.comStructure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent HighlightsMarch 8, 2024 | markets.businessinsider.comBuy Rating Affirmed for Structure Therapeutics Amidst Competitive Landscape and Promising Drug Prospects Get Structure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. GPCR Media Mentions By Week GPCR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GPCR News Sentiment▼1.070.55▲Average Medical News Sentiment GPCR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GPCR Articles This Week▼92▲GPCR Articles Average Week Get Structure Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GPCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Agios Pharmaceuticals News Evotec News Galapagos News Catalyst Pharmaceuticals News Harmony Biosciences News NewAmsterdam Pharma News Syndax Pharmaceuticals News Edgewise Therapeutics News Schrödinger News Supernus Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GPCR) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsHow Biden has already won 2024Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityGold Set to EXPLODE!Gold Safe ExchangeBiden FINISHED On June 13th?Paradigm PressThe 1,000X Crypto PlaybookTrue Market InsidersWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
